U.S. Cell And Gene Therapy Clinical Trial Services Market (2024 - 2030) Size, Share & Trends Analysis Report By Service (Site Identification, Patient Recruitment), By Phase (Phase I, Phase II), By Therapeutic Areas, By Therapy Type, And Segment Forecasts

Market Segmentation

U.S. Cell and Gene Therapy Clinical Trial Service Outlook (Revenue, USD Million, 2018 - 2030)
- Site Identification
- Patient Recruitment
- Laboratory Services
- Regulatory Services
- Supply and Logistic Services
  - Logistics & Distribution
  - Storage & Retention
  - Packaging, Labeling, And Blinding
  - Manufacturing
  - Comparator Sourcing
  - Regulatory and customs support
  - Other Services
- Others
U.S. Cell and Gene Therapy Clinical Trial Services Phase Outlook (Revenue, USD Million, 2018 - 2030)
- Phase I
- Phase II
- Phase III
- Phase IV
U.S. Cell and Gene Therapy Clinical Trial Services Therapeutic Areas Outlook (Revenue, USD Million, 2018 - 2030)
- Oncology
- Central Nervous System (CNS) Disorders
- Cardiovascular Diseases
- Infectious Diseases
- Musculoskeletal
- Others
U.S. Cell and Gene Therapy Clinical Trial Services Therapy Type Outlook (Revenue, USD Million, 2018 - 2030)
- Gene Therapy
- Gene-modified Cell Therapy
- Cell Therapy

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments